InvestorsHub Logo
Followers 43
Posts 887
Boards Moderated 0
Alias Born 01/18/2019

Re: None

Thursday, 06/27/2019 2:54:36 PM

Thursday, June 27, 2019 2:54:36 PM

Post# of 71147
I've seen a few posts about GSCG cannot operate legally in the U.S.

Well, that's a false accusation:

"Global Stem Cells Group has announced plans to hold clinical trials, pending IRB approval, for bone marrow stem cell treatments targeting knee osteoarthritis. The trials will be held in five GSCG facilities in the U.S. and South America, with 25 patients accepted for each location."

"The clinical trials, which will run for one year, will be held in Global Stem Cell Group facilities in Buenos Aires, Argentina; Bogota, Colombia; Quito, Ecuador; Miami, Florida and Topeka, Kansas. Each center will accept 25 patients per clinical trial, and patients will receive a bone marrow stem cell injection in one knee and a placebo in the other knee."


[color=red][/color]All posts in the OTC are opinion and speculation based on individual DD..don't get personal.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.